| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9373455 | Journal of Pediatric Surgery | 2005 | 5 Pages |
Abstract
Neuroblastoma initially upregulates CCR7 expression by DC. However, with tumor progression, this chemokine is downregulated, likely leading to impaired DC migration. Immunotherapeutic strategies to bypass or augment CCR7-dependent DC trafficking may improve survival for patients with aggressive disease.
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
Sonya R. Walker, Alexander Aboka, P. Dafé Ogagan, Edward M. Jr,